Regulatory Information
HSA regulatory responsibility and product classification details
Regulatory Responsibility
RegistrantINOVA PHARMACEUTICALS (SINGAPORE) PTE. LIMITED
Licence HolderINOVA PHARMACEUTICALS (SINGAPORE) PTE. LIMITED
Product Classification
D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification
Formulation Information
TABLET, FILM COATED
**DOSAGE AND ADMINISTRATION** One to two tablets four times daily or as directed by physician. When used for patients with renal dysfunction the specially formulated film coating allows the whole tablet to be swallowed with a minimum of water.
ORAL
Medical Information
**INDICATIONS** Symptomatic relief of uncomplicated peptic ulcer and gastric hyperacidity. Phosphate binding in renal dysfunction.
**CONTRAINDICATIONS** Hypophosphataemia.
A02AB01
aluminium hydroxide
Manufacturer Information
INOVA PHARMACEUTICALS (SINGAPORE) PTE. LIMITED
Adcock Ingram Limited